Murray International Recalls Unapproved Flucinonide Ointment Cream
Murray International Trading Co., Inc. is recalling 97 boxes of FUQINGSONG RELIEF CREAM because it is marketed as a dietary supplement but bears drug claims, making it an unapproved drug.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation where use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences. The source text does not report any specific injuries, illnesses, or fatalities, and the hazard is regulatory (unapproved drug status) rather than a specific physical or chemical contamination with reported harm.
Plain-English summary
Murray International Trading Co., Inc. is recalling 97 boxes of FUQINGSONG RELIEF CREAM (Flucinonide Ointment). The product is packaged in 50-count individually labeled pieces, with a net weight of 0.32oz (10g) per piece within a box. The cream is manufactured by Tianjin Medical & Pharmaceutical Co., Ltd. in Tianjin City, China, and the remaining labeling contains Chinese characters.
The recall is being conducted because the product is marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). Although the product is marked as a dietary supplement, its labeling includes drug and disease claims, which classifies it as an unapproved drug under FDA regulations.
The recalled product was distributed nationwide and in Puerto Rico. All lots are affected. Consumers who have purchased this product should stop using it and contact the recalling firm for further instructions.
The recalled product
- Product
- FUQINGSONG RELIEF CREAM (Flucinonide Ointment), packaged in 50-count individually labeled pieces Net Wt. 0.32oz (10g) within a box, MANUFACTURED BY: TIANJIN MAEDICAL & PHARMACEUTICAL CO., LTD. ADDREST: 96 BAWAEI ROAD, HEDONG COUNTY, TIANJIN CITY, remaining labeling contains Chine
- Manufacturer
- Murray International Trading Co., Inc.
- Category
- Drug — Topical Ointment
- Affected units
- 97
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Part of a larger recall action
This product is one of 14 recalled by Murray International Trading Co., Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · Murray International Trading Co., Inc.
See all →- HighHerbal Doctor Angelicae Sinensis Recalled for Elevated Lead and Cadmium
FDA (Food) · 2021-12-08
- ModerateGastrodia Capsules Recalled for Unapproved Drug Claims
FDA (Drugs) · 2016-07-20
- ModerateMurray International Trading Recalls Farser Kai Yeung Pill for Unapproved Drug Claims
FDA (Drugs) · 2016-07-20
- SevereFUCONPO Capsule Recalled for Marketing Without Approved NDA or ANDA
FDA (Drugs) · 2016-07-20
- ModerateMurray International Recalls Tien Ma Tou Tong Wan Pills for Unapproved Drug Claims
FDA (Drugs) · 2016-07-20
Same hazard · unapproved drug
See all →- CriticalBuy-Herbal Recalls Kian Pee Wan Capsules for Undeclared Drug Ingredients
FDA (Drugs) · 2026-08-19
- SevereMR. 7 Super capsules recalled as Class I over undeclared sildenafil
FDA (Drugs) · 2026-03-11
- SevereMojo Max Fusion capsules recalled as Class I over undeclared drug ingredients
FDA (Drugs) · 2026-03-11
- SevereSilintan herbal pills recalled as Class I for undeclared meloxicam
FDA (Drugs) · 2026-03-11
- SevereAgebox iKids-Growth Day Formula Capsules Recalled Over Undeclared Drug Ingredient
FDA (Drugs) · 2026-03-04